Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 31OTHER_GOV 1INDUSTRY 1FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic adenoma 1Pancreatic Neoplasms 1Pancreatic Cyst 1Lymphadenopathy 1Cysts 1Arachnodactyly 1Adenoma, Islet Cell 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 297Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Endoscopic Ultrasound-Guided Fine Needle Aspiration × Clear all
NCT01563133 2017-08-29

CONTACT

Mauna Kea Technologies

Phase NA Unknown
330 enrolled
Gastrointestinal

Pancreatic adenoma, Lymphadenopathy, Cysts, Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Neoplasms, Arachnodactyly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡